{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:40:34Z","timestamp":1793644834932,"version":"4.5.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,6,21]],"date-time":"2010-06-21T00:00:00Z","timestamp":1277078400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1741-7015-8-37","type":"journal-article","created":{"date-parts":[[2010,6,22]],"date-time":"2010-06-22T02:15:31Z","timestamp":1277172931000},"source":"Crossref","is-referenced-by-count":361,"title":["The impact of herpes zoster and post-herpetic neuralgia on quality-of-life"],"prefix":"10.1186","volume":"8","author":[{"given":"Robert W","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Bouhassira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kassianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Lepl\u00e8ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E","family":"Schmader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Weinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,21]]},"reference":[{"key":"296_CR1","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1056\/NEJMct066061","volume":"356","author":"DW Kimberlin","year":"2007","unstructured":"Kimberlin DW, Whitley RJ: Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med. 2007, 356: 1338-1343. 10.1056\/NEJMct066061.","journal-title":"N Engl J Med"},{"key":"296_CR2","first-page":"9","volume":"58","author":"RE Hope-Simpson","year":"1965","unstructured":"Hope-Simpson RE: The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965, 58: 9-20.","journal-title":"Proc R Soc Med"},{"key":"296_CR3","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1056\/NEJMp058091","volume":"352","author":"A Arvin","year":"2005","unstructured":"Arvin A: Aging, immunity, and the varicella-zoster virus. N Engl J Med. 2005, 352: 2266-2267. 10.1056\/NEJMp058091.","journal-title":"N Engl J Med"},{"key":"296_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2165\/00128071-200506050-00005","volume":"6","author":"A Volpi","year":"2005","unstructured":"Volpi A, Gross G, Hercogova J, Johnson RW: Current management of herpes zoster: the European view. Am J Clin Dermatol. 2005, 6: 317-325. 10.2165\/00128071-200506050-00005.","journal-title":"Am J Clin Dermatol"},{"key":"296_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJMcp013211","volume":"347","author":"JW Gnann Jr","year":"2002","unstructured":"Gnann JW, Whitley RJ: Clinical practice: herpes zoster. N Engl J Med. 2002, 347: 340-346. 10.1056\/NEJMcp013211.","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"296_CR6","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/S1201-9712(07)60021-6","volume":"11","author":"R Johnson","year":"2007","unstructured":"Johnson R, McElhaney J, Pedalino B, Levin M: Prevention of herpes zoster and its painful and debilitating complications. Int J Infect Dis. 2007, 11 (Suppl 2): S43-S48. 10.1016\/S1201-9712(07)60021-6.","journal-title":"Int J Infect Dis"},{"key":"296_CR7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/CMR.9.3.361","volume":"9","author":"AM Arvin","year":"1996","unstructured":"Arvin AM: Varicella-zoster virus. Clin Microbiol Rev. 1996, 9: 361-381.","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 2","key":"296_CR8","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.1086\/522152","volume":"197","author":"K Schmader","year":"2008","unstructured":"Schmader K, Gnann JW, Watson CP: The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis. 2008, 197 (Suppl 2): S207-S215. 10.1086\/522152.","journal-title":"J Infect Dis"},{"key":"296_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/fampra\/19.5.471","volume":"19","author":"W Opstelten","year":"2002","unstructured":"Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA, van Essen GA: Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract. 2002, 19: 471-475. 10.1093\/fampra\/19.5.471.","journal-title":"Fam Pract"},{"issue":"Suppl 1","key":"296_CR10","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.jpain.2007.10.008","volume":"9","author":"RH Dworkin","year":"2008","unstructured":"Dworkin RH, Gnann JW, Oaklander AL, Raja SN, Schmader KE, Whitley RJ: Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain. 2008, 9 (Suppl 1): S37-S44. 10.1016\/j.jpain.2007.10.008.","journal-title":"J Pain"},{"issue":"Suppl 2","key":"296_CR11","first-page":"30A","volume":"14","author":"RW Johnson","year":"2007","unstructured":"Johnson RW: Zoster-associated pain: what is known, who is at risk and how can it be managed?. Herpes. 2007, 14 (Suppl 2): 30A-34A.","journal-title":"Herpes"},{"key":"296_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7326\/0003-4819-145-5-200609050-00004","volume":"145","author":"J Hornberger","year":"2006","unstructured":"Hornberger J, Robertus K: Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Ann Intern Med. 2006, 145: 317-325.","journal-title":"Ann Intern Med"},{"key":"296_CR13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jpain.2005.01.359","volume":"6","author":"G Oster","year":"2005","unstructured":"Oster G, Harding G, Dukes E, Edelsberg J, Cleary PD: Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J Pain. 2005, 6: 356-363. 10.1016\/j.jpain.2005.01.359.","journal-title":"J Pain"},{"key":"296_CR14","first-page":"2731","volume-title":"Fields Virology","author":"AM Arvin","year":"2001","unstructured":"Arvin AM: Varicella-zoster virus. Fields Virology. Edited by: Knipe DM, Howley PM. 2001, Philadelphia: Lippincott Williams & Wilkins, 2: 2731-2768. 4","edition":"4"},{"key":"296_CR15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/BF03324909","volume":"21","author":"RW Johnson","year":"2009","unstructured":"Johnson RW: Herpes zoster and postherpetic neuralgia: a review of the effects of vaccination. Aging Clin Exp Res. 2009, 21: 236-243.","journal-title":"Aging Clin Exp Res"},{"key":"296_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1017\/S0950268808000678","volume":"137","author":"A Gauthier","year":"2009","unstructured":"Gauthier A, Breuer J, Carrington D, Martin M, R\u00e9my V: Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect. 2009, 137: 38-47. 10.1017\/S0950268808000678.","journal-title":"Epidemiol Infect"},{"key":"296_CR17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.vaccine.2008.11.012","volume":"27","author":"AN Stein","year":"2009","unstructured":"Stein AN, Britt H, Harrison C, Conway EL, Cunningham A, Macintyre CR: Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine. 2009, 27: 520-529. 10.1016\/j.vaccine.2008.11.012.","journal-title":"Vaccine"},{"key":"296_CR18","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1086\/421942","volume":"39","author":"J Katz","year":"2004","unstructured":"Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH: Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis. 2004, 39: 342-348. 10.1086\/421942.","journal-title":"Clin Infect Dis"},{"key":"296_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jpain.2004.06.001","volume":"5","author":"PM Coplan","year":"2004","unstructured":"Coplan PM, Schmader K, Nikas A, Chan IS, Choo P, Levin MJ, Johnson G, Bauer M, Williams HM, Kaplan KM, Guess HA, Oxman MN: Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain. 2004, 5: 344-356. 10.1016\/j.jpain.2004.06.001.","journal-title":"J Pain"},{"issue":"Suppl 2","key":"296_CR20","first-page":"35A","volume":"14","author":"A Volpi","year":"2007","unstructured":"Volpi A: Severe complications of herpes zoster. Herpes. 2007, 14 (Suppl 2): 35A-39A.","journal-title":"Herpes"},{"key":"296_CR21","volume-title":"Constitution of the World Health Organization. Basic Documents","author":"World Health Organization","year":"2006","unstructured":"World Health Organization: Constitution of the World Health Organization. Basic Documents. 2006, Geneva: WHO, 45","edition":"45"},{"key":"296_CR22","volume-title":"The Quality of Life Model","author":"University of Toronto","year":"2009","unstructured":"University of Toronto: The Quality of Life Model. 2009, [ http:\/\/www.utoronto.ca\/qol\/concepts.htm ]"},{"key":"296_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.pain.2003.08.001","volume":"106","author":"DC Turk","year":"2003","unstructured":"Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrar JT, Galer BS, et al: Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003, 106: 337-345. 10.1016\/j.pain.2003.08.001.","journal-title":"Pain"},{"key":"296_CR24","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1086\/515205","volume":"28","author":"K Schmader","year":"1999","unstructured":"Schmader K: Herpes zoster in the elderly: issues related to geriatrics. Clin Infect Dis. 1999, 28: 736-739. 10.1086\/515205.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 9","key":"296_CR25","first-page":"S218","volume":"13","author":"D Khanna","year":"2007","unstructured":"Khanna D, Tsevat J: Health-related quality of life - an introduction. Am J Manag Care. 2007, 13 (Suppl 9): S218-S223.","journal-title":"Am J Manag Care"},{"key":"296_CR26","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/AJP.0b013e318065b6c9","volume":"23","author":"KE Schmader","year":"2007","unstructured":"Schmader KE, Sloane R, Pieper C, Coplan PM, Nikas A, Saddier P, Chan IS, Choo P, Levin MJ, Johnson G, et al: The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain. 2007, 23: 490-496. 10.1097\/AJP.0b013e318065b6c9.","journal-title":"Clin J Pain"},{"key":"296_CR27","volume-title":"Measuring aspects of daily life in patients with herpes zoster","author":"J Norquist","year":"2005","unstructured":"Norquist J, Nikas A, Saddier P, Choo P, Levin M, Oxman M, Schmader K: Measuring aspects of daily life in patients with herpes zoster. 2005, San Francisco, CA, USA, (Abstract). International Society for Quality of Life Research, 12th Annual Conference"},{"key":"296_CR28","doi-asserted-by":"publisher","first-page":"991","DOI":"10.2165\/0002512-200825120-00002","volume":"25","author":"RW Johnson","year":"2008","unstructured":"Johnson RW, Wasner G, Saddier P, Baron R: Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient. Drugs Aging. 2008, 25: 991-1006. 10.2165\/0002512-200825120-00002.","journal-title":"Drugs Aging"},{"issue":"Suppl 2","key":"296_CR29","first-page":"25","volume":"14","author":"J Breuer","year":"2007","unstructured":"Breuer J, Whitley R: Varicella zoster virus: natural history and current therapies of varicella and herpes zoster. Herpes. 2007, 14 (Suppl 2): 25-29. [Erratum in Herpes 2007, 14: 74]","journal-title":"Herpes"},{"key":"296_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0039-6109(05)70381-9","volume":"79","author":"J Katz","year":"1999","unstructured":"Katz J, Melzack R: Measurement of pain. Surg Clin North Am. 1999, 79: 231-252. 10.1016\/S0039-6109(05)70381-9.","journal-title":"Surg Clin North Am"},{"key":"296_CR31","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/archinte.1997.00440320117011","volume":"157","author":"PW Choo","year":"1997","unstructured":"Choo PW, Galil K, Donahue JG, Walker AM, Spiegelman D, Platt R: Risk factors for postherpetic neuralgia. Arch Intern Med. 1997, 157: 1217-1224. 10.1001\/archinte.157.11.1217.","journal-title":"Arch Intern Med"},{"issue":"Suppl 1","key":"296_CR32","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1086\/514274","volume":"178","author":"RJ Whitley","year":"1998","unstructured":"Whitley RJ, Shukla S, Crooks RJ: The identification of risk factors associated with persistent pain following herpes zoster. J Infect Dis. 1998, 178 (Suppl 1): S71-S75. 10.1086\/514274.","journal-title":"J Infect Dis"},{"key":"296_CR33","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1212\/01.WNL.0000123261.00004.29","volume":"62","author":"BF Jung","year":"2004","unstructured":"Jung BF, Johnson RW, Griffin DR, Dworkin RH: Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology. 2004, 62: 1545-1551.","journal-title":"Neurology"},{"key":"296_CR34","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/jmv.21254","volume":"80","author":"A Volpi","year":"2008","unstructured":"Volpi A, Gatti A, Pica F, Bellino S, Marsella LT, Sabato AF: Clinical and psychosocial correlates of post-herpetic neuralgia. J Med Virol. 2008, 80: 1646-1652. 10.1002\/jmv.21254.","journal-title":"J Med Virol"},{"key":"296_CR35","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1017\/CBO9780511601194.016","volume-title":"Varicella-Zoster Virus, Virology and Clinical Management","author":"D Pavan-Langston","year":"2000","unstructured":"Pavan-Langston D: Ophthalmic zoster. Varicella-Zoster Virus, Virology and Clinical Management. Edited by: Arvin AM, Gershon AA. 2000, Cambridge Press, 276-298. full_text."},{"issue":"Suppl 8","key":"296_CR36","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1212\/WNL.45.12_Suppl_8.S52","volume":"45","author":"E Lydick","year":"1995","unstructured":"Lydick E, Epstein RS, Himmelberger D, White CJ: Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology. 1995, 45 (Suppl 8): S52-S53.","journal-title":"Neurology"},{"key":"296_CR37","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1086\/320169","volume":"32","author":"K Schmader","year":"2001","unstructured":"Schmader K: Herpes zoster in older adults. Clin Infect Dis. 2001, 32: 1481-1486. 10.1086\/320169.","journal-title":"Clin Infect Dis"},{"key":"296_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1086\/320884","volume":"33","author":"C Chidiac","year":"2001","unstructured":"Chidiac C, Bruxelle J, Daures JP, Hoang-Xuan T, Morel P, Lepl\u00e8ge A, Hasnaoui A El, de Labareyre C: Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis. 2001, 33: 62-69. 10.1086\/320884.","journal-title":"Clin Infect Dis"},{"key":"296_CR39","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1526-5900(03)00637-0","volume":"4","author":"AL Oaklander","year":"2003","unstructured":"Oaklander AL, Bowsher D, Galer B, Haanp\u00e4\u00e4 M, Jensen MP: Herpes zoster itch: preliminary epidemiologic data. J Pain. 2003, 4: 338-343. 10.1016\/S1526-5900(03)00637-0.","journal-title":"J Pain"},{"key":"296_CR40","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/ageing\/afj048","volume":"35","author":"R van Seventer","year":"2006","unstructured":"van Seventer R, Sadosky A, Lucero M, Dukes E: A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia. Age Ageing. 2006, 35: 132-137. 10.1093\/ageing\/afj048.","journal-title":"Age Ageing"},{"key":"296_CR41","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/00002508-200211000-00002","volume":"18","author":"KE Schmader","year":"2002","unstructured":"Schmader KE: Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002, 18: 350-354. 10.1097\/00002508-200211000-00002.","journal-title":"Clin J Pain"},{"key":"296_CR42","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/BF00435395","volume":"3","author":"J Mauskopf","year":"1994","unstructured":"Mauskopf J, Austin R, Dix L, Berzon R: The Nottingham Health Profile as a measure of quality of life in zoster patients: convergent and discriminant validity. Qual Life Res. 1994, 3: 431-435. 10.1007\/BF00435395.","journal-title":"Qual Life Res"},{"key":"296_CR43","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.cger.2007.03.003","volume":"23","author":"K Schmader","year":"2007","unstructured":"Schmader K: Herpes zoster and postherpetic neuralgia in older adults. Clin Geriatr Med. 2007, 23: 615-632. 10.1016\/j.cger.2007.03.003. vii-viii","journal-title":"Clin Geriatr Med"},{"key":"296_CR44","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1517\/14656566.5.3.551","volume":"5","author":"RW Johnson","year":"2004","unstructured":"Johnson RW, Whitton TL: Management of herpes zoster (shingles) and postherpetic neuralgia. Expert Opin Pharmacother. 2004, 5: 551-559. 10.1517\/14656566.5.3.551.","journal-title":"Expert Opin Pharmacother"},{"key":"296_CR45","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1161\/STROKEAHA.109.562017","volume":"40","author":"JH Kang","year":"2009","unstructured":"Kang JH, Ho JD, Chen YH, Lin HC: Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke. 2009, 40: 3443-3448. 10.1161\/STROKEAHA.109.562017.","journal-title":"Stroke"},{"key":"296_CR46","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1212\/WNL.0b013e3181d31e5c","volume":"74","author":"HC Lin","year":"2010","unstructured":"Lin HC, Chien CW, Ho JD: Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology. 2010, 74: 792-797. 10.1212\/WNL.0b013e3181d31e5c.","journal-title":"Neurology"},{"key":"296_CR47","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.4065\/82.11.1341","volume":"82","author":"BP Yawn","year":"2007","unstructured":"Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS: A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007, 82: 1341-1349. 10.4065\/82.11.1341. [Erratum in: Mayo Clin Proc 2008; 83: 255]","journal-title":"Mayo Clin Proc"},{"key":"296_CR48","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0163-4453(99)90079-8","volume":"38","author":"U di Luzio Paparatti","year":"1999","unstructured":"di Luzio Paparatti U, Arpinelli F, Vison\u00e0 G: Herpes zoster and its complications in Italy: an observational survey. J Infect. 1999, 38: 116-120. 10.1016\/S0163-4453(99)90079-8.","journal-title":"J Infect"},{"key":"296_CR49","volume-title":"J Public Health","author":"T Weinke","year":"2010","unstructured":"Weinke T, Edte S, Schmitt S, Lukas K: Impact of herpes zoster and post-herpetic neuralgia on patients' quality of life: a patient-reported outcomes survey. J Public Health. 2010"},{"key":"296_CR50","volume-title":"Impacto del herpes z\u00f3ster con o sin neuralgia postherp\u00e9tica en la calidad de vida de los pacientes","author":"MJ \u00c1lvarez Pasqu\u00edn","year":"2008","unstructured":"\u00c1lvarez Pasqu\u00edn MJ, Morat\u00f3 Agust\u00ed ML, San-Mart\u00edn Rodr\u00edguez M, y Grupo EPIZOSTER: Impacto del herpes z\u00f3ster con o sin neuralgia postherp\u00e9tica en la calidad de vida de los pacientes. 2008, Madrid, Spain, [Impact of HZ with or without PHN on patients' QoL]. Abstract. Congress Sociedad Espa\u00f1ola de Medicina de Familia y Comunitaria, Accessed 7 October 2009, [ http:\/\/congreso2008.semfyc.gatewaysc.com\/archivos\/file\/Madrid202008\/Posters%20web%20final.pdf ]"},{"key":"296_CR51","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/01.FCH.0000290543.48576.cf","volume":"30","author":"AN Baanders","year":"2007","unstructured":"Baanders AN, Heijmans MJ: The impact of chronic diseases: the partner's perspective. Fam Community Health. 2007, 30: 305-317.","journal-title":"Fam Community Health"},{"key":"296_CR52","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.vaccine.2005.09.026","volume":"24","author":"FT Scott","year":"2006","unstructured":"Scott FT, Johnson RW, Leedham-Green M, Davies E, Edmunds WJ, Breuer J: The burden of Herpes Zoster: a prospective population based study. Vaccine. 2006, 24: 1308-1314. 10.1016\/j.vaccine.2005.09.026.","journal-title":"Vaccine"},{"key":"296_CR53","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.vaccine.2008.12.024","volume":"27","author":"AJ van Hoek","year":"2009","unstructured":"van Hoek AJ, Gay N, Melegaro A, Opstelten W, Edmunds WJ: Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales. Vaccine. 2009, 27: 1454-1467. 10.1016\/j.vaccine.2008.12.024.","journal-title":"Vaccine"},{"key":"296_CR54","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1016\/j.vaccine.2006.02.017","volume":"24","author":"H de Melker","year":"2006","unstructured":"de Melker H, Berbers G, Hahn\u00e9 S, R\u00fcmke H, van den Hof S, de Wit A, Boot H: The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine. 2006, 24: 3946-3952. 10.1016\/j.vaccine.2006.02.017.","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"296_CR55","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1002\/jmv.10313","volume":"70","author":"M Brisson","year":"2003","unstructured":"Brisson M, Edmunds WJ: Epidemiology of varicella-zoster virus in England and Wales. J Med Virol. 2003, 70 (Suppl 1): S9-S14. 10.1002\/jmv.10313.","journal-title":"J Med Virol"},{"key":"296_CR56","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s001050050476","volume":"47","author":"E Paul","year":"1996","unstructured":"Paul E, Thiel T: Epidemiology of varicella zoster infection. Results of a prospective study in the Ansbach area. Hautarzt. 1996, 47: 604-609. 10.1007\/s001050050476. [in German]","journal-title":"Hautarzt"},{"key":"296_CR57","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1016\/S0264-410X(01)00044-5","volume":"19","author":"WJ Edmunds","year":"2001","unstructured":"Edmunds WJ, Brisson M, Rose JD: The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine. 2001, 19: 3076-3090. 10.1016\/S0264-410X(01)00044-5.","journal-title":"Vaccine"},{"key":"296_CR58","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1086\/315492","volume":"181","author":"F Lin","year":"2000","unstructured":"Lin F, Hadler JL: Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era. J Infect Dis. 2000, 181: 1897-1905. 10.1086\/315492.","journal-title":"J Infect Dis"},{"key":"296_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1586\/erv.10.31","volume":"9","author":"JE McElhaney","year":"2010","unstructured":"McElhaney JE: Herpes zoster: a common disease that can have a devastating impact on patients' quality of life. Expert Rev Vaccines. 2010, 9: 27-30. 10.1586\/erv.10.31.","journal-title":"Expert Rev Vaccines"},{"issue":"Suppl 1","key":"296_CR60","first-page":"21A","volume":"13","author":"RH Dworkin","year":"2006","unstructured":"Dworkin RH: Post-herpetic neuralgia. Herpes. 2006, 13 (Suppl 1): 21A-27A.","journal-title":"Herpes"},{"key":"296_CR61","first-page":"1","volume":"57","author":"R Harpaz","year":"2008","unstructured":"Harpaz R, Ortega-Sanchez IR, Seward JF: Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008, 57: 1-30. [Erratum in MMWR Recomm Rep 2008; 57: 779]","journal-title":"MMWR Recomm Rep"},{"issue":"Suppl 1","key":"296_CR62","first-page":"S8","volume":"107","author":"KE Galluzzi","year":"2007","unstructured":"Galluzzi KE: Management strategies for herpes zoster and postherpetic neuralgia. J Am Osteopath Assoc. 2007, 107 (Suppl 1): S8-S13.","journal-title":"J Am Osteopath Assoc"},{"key":"296_CR63","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/clinids\/22.2.341","volume":"22","author":"MJ Wood","year":"1996","unstructured":"Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ: Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis. 1996, 22: 341-347.","journal-title":"Clin Infect Dis"},{"key":"296_CR64","first-page":"CD006866","volume":"2","author":"Q Li","year":"2009","unstructured":"Li Q, Chen N, Yang J, Zhou M, Zhou D, Zhang Q, He L: Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2009, 2: CD006866.","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"296_CR65","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1086\/510206","volume":"44","author":"RH Dworkin","year":"2007","unstructured":"Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, Betts RF, Gershon AA, Haanpaa ML, McKendrick MW, Nurmikko TJ, et al: Recommendations for the management of herpes zoster. Clin Infect Dis. 2007, 44 (Suppl 1): S1-26. 10.1086\/510206.","journal-title":"Clin Infect Dis"},{"key":"296_CR66","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/j.1742-1241.2009.02089.x","volume":"63","author":"RW Johnson","year":"2009","unstructured":"Johnson RW, McElhaney J: Postherpetic neuralgia in the elderly. Int J Clin Pract. 2009, 63: 1386-1391. 10.1111\/j.1742-1241.2009.02089.x.","journal-title":"Int J Clin Pract"},{"key":"296_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00002512-200724010-00001","volume":"24","author":"PJ Christo","year":"2007","unstructured":"Christo PJ, Hobelmann G, Maine DN: Post-herpetic neuralgia in older adults: evidence-based approaches to clinical management. Drugs Aging. 2007, 24: 1-19. 10.2165\/00002512-200724010-00001.","journal-title":"Drugs Aging"},{"key":"296_CR68","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","volume":"118","author":"NB Finnerup","year":"2005","unstructured":"Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH: Algorithm for neuropathic pain treatment: an evidence-based proposal. Pain. 2005, 118: 289-305. 10.1016\/j.pain.2005.08.013.","journal-title":"Pain"},{"key":"296_CR69","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2165\/00019053-200826030-00006","volume":"26","author":"TA Lieu","year":"2008","unstructured":"Lieu TA, Ortega-Sanchez I, Ray GT, Rusinak D, Yih WK, Choo PW, Shui I, Kleinman K, Harpaz R, Prosser LA: Community and patient values for preventing herpes zoster. Pharmacoeconomics. 2008, 26: 235-249. 10.2165\/00019053-200826030-00006.","journal-title":"Pharmacoeconomics"},{"key":"296_CR70","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, et al: A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005, 352: 2271-2284. 10.1056\/NEJMoa051016.","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"296_CR71","doi-asserted-by":"publisher","first-page":"S228","DOI":"10.1086\/522159","volume":"197","author":"MN Oxman","year":"2008","unstructured":"Oxman MN, Levin MJ, Shingles Prevention Study Group: Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis. 2008, 197 (Suppl 2): S228-S236. 10.1086\/522159.","journal-title":"J Infect Dis"},{"key":"296_CR72","volume-title":"The effect of a zoster vaccine on interference of herpes zoster with activities of daily living (ADL)","author":"K Schmader","year":"2006","unstructured":"Schmader K, Saddier P, Johnson G, et al: The effect of a zoster vaccine on interference of herpes zoster with activities of daily living (ADL). 2006, Toronto, Canada, Abstract 859, 44th Annual Meeting of the Infectious Diseases Society of America"},{"key":"296_CR73","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.jpain.2007.10.007","volume":"9","author":"JW Gnann Jr","year":"2008","unstructured":"Gnann JW: Vaccination to prevent herpes zoster in older adults. J Pain. 2008, 9: S31-S36. 10.1016\/j.jpain.2007.10.007.","journal-title":"J Pain"},{"key":"296_CR74","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/00003226-199909000-00002","volume":"18","author":"TJ Liesegang","year":"1999","unstructured":"Liesegang TJ: Varicella-zoster virus eye disease. Cornea. 1999, 18: 511-531.","journal-title":"Cornea"},{"key":"296_CR75","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1371\/journal.pmed.0020164","volume":"2","author":"K Hempenstall","year":"2005","unstructured":"Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS: Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med. 2005, 2: e164-10.1371\/journal.pmed.0020164.","journal-title":"PLoS Med"},{"issue":"Suppl 1","key":"296_CR76","first-page":"16A","volume":"13","author":"JW Gnann Jr","year":"2006","unstructured":"Gnann JW: Antiviral therapy for herpes zoster. Herpes. 2006, 13 (Suppl 1): 16A-20A.","journal-title":"Herpes"},{"key":"296_CR77","doi-asserted-by":"publisher","first-page":"89","DOI":"10.7326\/0003-4819-123-2-199507150-00002","volume":"123","author":"S Tyring","year":"1995","unstructured":"Tyring S, Barbarash RA, Nahlik JE, Cunningham A, Marley J, Heng M, Jones T, Rea T, Boon R, Saltzman R: Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med. 1995, 123: 89-96.","journal-title":"Ann Intern Med"},{"key":"296_CR78","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0166-3542(95)00066-6","volume":"28","author":"KR Beutner","year":"1995","unstructured":"Beutner KR: Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy. Antiviral Res. 1995, 28: 281-290. 10.1016\/0166-3542(95)00066-6.","journal-title":"Antiviral Res"},{"key":"296_CR79","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/archneur.63.7.noc60049","volume":"63","author":"D Quan","year":"2006","unstructured":"Quan D, Hammack BN, Kittelson J, Gilden DH: Improvement of postherpetic neuralgia after treatment with intravenous acyclovir followed by oral valacyclovir. Arch Neurol. 2006, 63: 940-942. 10.1001\/archneur.63.7.noc60049.","journal-title":"Arch Neurol"},{"key":"296_CR80","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJM199403313301304","volume":"330","author":"MJ Wood","year":"1994","unstructured":"Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J: A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med. 1994, 330: 896-900. 10.1056\/NEJM199403313301304.","journal-title":"N Engl J Med"},{"key":"296_CR81","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0166-3542(95)00920-5","volume":"29","author":"RJ Whitley","year":"1996","unstructured":"Whitley RJ, Gnann JW, Weiss HL, Soong SJ: Unique clinical trial design: combination acyclovir plus prednisone therapy of localized zoster in the normal host. Antiviral Res. 1996, 29: 67-68. 10.1016\/0166-3542(95)00920-5.","journal-title":"Antiviral Res"},{"key":"296_CR82","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1212\/01.WNL.0000055433.55136.55","volume":"60","author":"RH Dworkin","year":"2003","unstructured":"Dworkin RH, Corbin AE, Young JP, Sharma U, LaMoreaux L, Bockbrader H, Garofalo EA, Poole RM: Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2003, 60: 1274-1283.","journal-title":"Neurology"},{"key":"296_CR83","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.pain.2004.01.001","volume":"109","author":"R Sabatowski","year":"2004","unstructured":"Sabatowski R, G\u00e1lvez R, Cherry DA, Jacquot F, Vincent E, Maisonobe P, Versavel M: Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain. 2004, 109: 26-35. 10.1016\/j.pain.2004.01.001.","journal-title":"Pain"},{"key":"296_CR84","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","volume":"280","author":"M Rowbotham","year":"1998","unstructured":"Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L: Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998, 280: 1837-1842. 10.1001\/jama.280.21.1837.","journal-title":"JAMA"},{"issue":"Suppl 2","key":"296_CR85","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.ophtha.2007.10.012","volume":"115","author":"D Pavan-Langston","year":"2008","unstructured":"Pavan-Langston D: Herpes zoster antivirals and pain management. Ophthalmology. 2008, 115 (Suppl 2): S13-S20. 10.1016\/j.ophtha.2007.10.012.","journal-title":"Ophthalmology"},{"key":"296_CR86","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S1474-4422(08)70228-X","volume":"7","author":"M Backonja","year":"2008","unstructured":"Backonja M, Wallace MS, Blonsky ER, Cutler BJ, Malan P, Rauck R, Tobias J: NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol. 2008, 7: 1106-1112. 10.1016\/S1474-4422(08)70228-X. NGX-4010 C116 Study Group [Erratum in Lancet Neurol 2009; 8: 31]","journal-title":"Lancet Neurol"},{"key":"296_CR87","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/00002508-200409000-00004","volume":"20","author":"H Manabe","year":"2004","unstructured":"Manabe H, Dan K, Hirata K, Hori K, Shono S, Tateshi S, Ishino H, Higa K: Optimum pain relief with continuous epidural infusion of local anesthetics shortens the duration of zoster-associated pain. Clin J Pain. 2004, 20: 302-308. 10.1097\/00002508-200409000-00004.","journal-title":"Clin J Pain"},{"key":"296_CR88","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1034\/j.1399-6576.2000.440803.x","volume":"44","author":"A Pasqualucci","year":"2000","unstructured":"Pasqualucci A, Pasqualucci V, Galla F, De Angelis V, Marzocchi V, Colussi R, Paoletti F, Girardis M, Lugano M, Del Sindaco F: Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta Anaesthesiol Scand. 2000, 44: 910-918. 10.1034\/j.1399-6576.2000.440803.x.","journal-title":"Acta Anaesthesiol Scand"},{"key":"296_CR89","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(06)68032-X","volume":"367","author":"AJ van Wijck","year":"2006","unstructured":"van Wijck AJ, Opstelten W, Moons KG, van Essen GA, Stolker RJ, Kalkman CJ, Verheij TJ: The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial. Lancet. 2006, 367: 219-224. 10.1016\/S0140-6736(06)68032-X.","journal-title":"Lancet"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-8-37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1741-7015-8-37\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-8-37","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T04:45:51Z","timestamp":1559191551000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/1741-7015-8-37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,21]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["296"],"URL":"https:\/\/doi.org\/10.1186\/1741-7015-8-37","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,21]]},"article-number":"37"}}